AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Research on the Relationship Between Scoliosis, Pain, Quality of Life, and Trunk Muscle Compensation Patterns Among Patients with Duchenne Muscular Dystrophy.

Recruitingn/aAges 11 Years - 30 YearsAllSeoul National University Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

* Objective: The objective of this observational study is to evaluate and quantify trunk muscle compensatory movement patterns in patients with Duchenne Muscular Dystrophy (DMD) using computer vision technology. Additionally, the study seeks to explore the relationship between these compensatory patterns and scoliosis, upper limb function, pain levels, and quality of life during functional upper limb movements. * Key Research Questions: 1\) Can trunk compensatory movement patterns be accurately measured using computer vision analysis? 2) Are these compensatory patterns correlated with scoliosis, upper limb function levels, pain, and quality of life? 3) Do these patterns and their correlations change over time? * Methodology: 1. Participants: Patients diagnosed with Duchenne Muscular Dystrophy will be recruited for this study. 2. Assessments: * Scoliosis Evaluation: 1. Cobb a

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
1. Inclusion Criteria (1) Duchenne Muscular Dystrophy (DMD) Group * Individuals with a confirmed genetic diagnosis of Duchenne Muscular Dystrophy. * Aged over 10 years but under 30 years. * Brooke Scale score between 2 and 5. * Shoulder abductor muscle strength below grade 3 on the Manual Muscle Test (MMT). (2) Healthy Control Group * Individuals with no history or current diagnosis of musculoskeletal or neuromuscular disorders. * Aged over 10 years but under 30 years. * Shoulder muscle strength of grade 4+ or higher on the Manual Muscle Test (MMT). * Individuals capable of understanding a detailed explanation of the study procedures and voluntarily providing written informed consent. 2. Exclusion Criteria (1) Duchenne Muscular Dystrophy (DMD) Group * Individuals unable or unwilling to provide informed consent. * Brooke Scale score of 1 or 6. * Severe cognitive impairment preventing the performance of simple tasks. (2) Healthy Control Group * Individuals unable or unwilling to provide informed consent. * Shoulder muscle strength of grade 4 or lower on the Manual Muscle Test (MMT).
๐Ÿ’Š

What it tests

  • Observational Assessment
๐Ÿ“

Where

1 site
Seoul National University Hospital
Seoul, South Korea
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy